BioXcel Therapeutics
BTAI
BTAI
39 hedge funds and large institutions have $7.27M invested in BioXcel Therapeutics in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.15M | |
| 2 | +$167K | |
| 3 | +$133K | |
| 4 |
Man Group
London,
United Kingdom
|
+$65.3K |
| 5 |
State Street
Boston,
Massachusetts
|
+$47.6K |
Top Sellers
| 1 | -$204K | |
| 2 | -$192K | |
| 3 | -$28K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$27.3K |
| 5 |
EGM
Engineers Gate Manager
New York
|
-$19.7K |
